Try GOLD - Free
AI IN CERVICAL CANCER DETECTION: THE FUTURE OF EARLY DIAGNOSIS IN INDIA
Healthcare Radius
|January 2025
The deployment of Al-based diagnostic tools must be carefully regulated to ensure that they meet safety and efficacy standards.

Cervical cancer is a leading cause of cancer-related deaths among women, and it continues to be an important public health issue in low- and middleincome countries. In India, cervical cancer is the second most common form of cancer in terms of both incidence and mortality, accounting for 18.3% of all cancers and 18.7% of female cancer deaths in 2020, as stated in a report by BioMed Central. Despite the availability of effective screening methods, including Pap smears and HPV testing, the disease is still killing hundreds of thousands every year. However, AI is emerging as a transformational tool in the early detection and diagnosis of cervical cancer. So, let's explore how AI is revolutionizing the future of cervical cancer detection in India, which will highlight its potential for improving the accuracy and efficiency of early diagnosis and collaboration necessary to realize this potential.
THE GROWING BURDEN OF CERVICAL CANCER IN INDIA
Cervical cancer remains a major public health issue in India, where the lack of widespread access to quality healthcare and screening programs exacerbates the problem. India accounts for a significant proportion of the global burden of cervical cancer, with an incidence rate that continues to rise, particularly in rural and underserved areas. The disease is primarily caused by persistent infection with high-risk types of human papillomavirus (HPV), particularly types 16 and 18. Although HPV vaccines are available, their uptake remains limited due to various socio-cultural and infrastructural barriers. Early detection through screening and timely treatment is critical in reducing mortality rates. Still, challenges such as limited access to healthcare resources, inadequate awareness, and a shortage of skilled professionals hinder effective screening efforts.
THE PROMISE OF AI IN CERVICAL CANCER DETECTION
This story is from the January 2025 edition of Healthcare Radius.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Healthcare Radius

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Listen
Translate
Change font size